The current study was designed to investigate the relationship between FGF19 and CAD in human patients, using coronary angiographic findings (the “gold standard” of CAD diagnosis) and the Gensini score (to assess the severity of CAD [10]) to perform a correlation analysis of the factor-disease interrelation, including relations with various demographic and clinical factors. This evidence concerns the gene FGF19 and coronary artery disorder.